Bivalirudin versus Heparin in Women Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis of Randomized Clinical Trials

The anticoagulant of choice during percutaneous coronary intervention (PCI) in women is not well established.

Source: Cardiovascular Revascularization Medicine - February 27, 2017 Category: Cardiology Authors: Marwan Saad, Ramez Nairooz, Ahmed Rashed, Hesham K. Abdelaziz, Amgad Mentias, J. Dawn Abbott Source Type: research